Dimensional Fund Advisors LP Boosts Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Dimensional Fund Advisors LP lifted its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 5.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 775,470 shares of the company’s stock after acquiring an additional 42,086 shares during the period. Dimensional Fund Advisors LP owned 1.91% of Phibro Animal Health worth $13,005,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of PAHC. CWM LLC increased its position in Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares during the last quarter. Fidelis Capital Partners LLC purchased a new stake in shares of Phibro Animal Health during the 1st quarter valued at $46,000. China Universal Asset Management Co. Ltd. grew its stake in shares of Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after buying an additional 1,531 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Phibro Animal Health during the 2nd quarter worth $83,000. Finally, Illinois Municipal Retirement Fund raised its position in shares of Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after buying an additional 765 shares during the period. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on PAHC shares. JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Bank of America increased their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $15.00.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $21.31 on Friday. The company has a debt-to-equity ratio of 1.79, a current ratio of 2.94 and a quick ratio of 1.64. Phibro Animal Health Co. has a 1-year low of $9.40 and a 1-year high of $22.84. The company has a market capitalization of $863.12 million, a price-to-earnings ratio of 66.59, a PEG ratio of 1.77 and a beta of 0.52. The business has a 50-day moving average of $20.04 and a 200-day moving average of $17.55.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. The firm had revenue of $273.16 million during the quarter, compared to analysts’ expectations of $262.44 million. On average, equities analysts anticipate that Phibro Animal Health Co. will post 1.44 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were issued a $0.12 dividend. The ex-dividend date was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.25%. Phibro Animal Health’s dividend payout ratio is currently 150.00%.

Insider Buying and Selling at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The shares were acquired at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now owns 25,000 shares in the company, valued at $500,500. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 50.06% of the stock is currently owned by corporate insiders.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.